97
Participants
Start Date
December 21, 2016
Primary Completion Date
January 14, 2019
Study Completion Date
April 1, 2019
SAR156597
Pharmaceutical form: Solution Route of administration: Subcutaneous
Placebo
Pharmaceutical form: Solution Route of administration: Subcutaneous
Investigational Site Number 0560002, Leuven
Investigational Site Number 0560001, Ghent
Investigational Site Number 3800006, Orbassano
Investigational Site Number 2760001, Berlin
Investigational Site Number 2330001, Tallinn
Investigational Site Number 3800004, Genova
Investigational Site Number 8400005, Washington D.C.
Investigational Site Number 3800001, Milan
Investigational Site Number 3800005, Milan
Investigational Site Number 4840001, Chihuahua City
Investigational Site Number 2500003, Montpellier
Investigational Site Number 4840005, Guadalajara
Investigational Site Number 8400002, Cleveland
Investigational Site Number 4840002, Guadalajara
Investigational Site Number 2760002, Cologne
Investigational Site Number 2760003, Bad Nauheim
Investigational Site Number 4840003, Monterrey
Investigational Site Number 2500002, Strasbourg
Investigational Site Number 2500004, Paris
Investigational Site Number 8400007, Houston
Investigational Site Number 2760004, Ulm
Investigational Site Number 8400006, San Francisco
Investigational Site Number 6430005, Moscow
Investigational Site Number 6430001, Moscow
Investigational Site Number 6430004, Moscow
Investigational Site Number 6420001, Cluj-Napoca
Investigational Site Number 6430003, Ufa
Investigational Site Number 6420002, Târgu Mureş
Investigational Site Number 6430002, Kemerovo
Investigational Site Number 0320003, Buenos Aires
Investigational Site Number 0320002, Caba
Investigational Site Number 0320005, Capital Federal
Investigational Site Number 0320001, San Miguel de Tucumán
Investigational Site Number 6160001, Poznan
Investigational Site Number 6160002, Warsaw
Investigational Site Number 6160003, Wroclaw
Investigational Site Number 6420003, Bucharest
Investigational Site Number 6420004, Bucharest
Investigational Site Number 6420005, Bucharest
Investigational Site Number 8040001, Kyiv
Investigational Site Number 8040002, Kyiv
Investigational Site Number 8040004, Kyiv
Investigational Site Number 8040003, Kyiv
Investigational Site Number 8260001, London
Lead Sponsor
Sanofi
INDUSTRY